BRAUSETABLETTEN, ENTHALTEND ALENDRONAT

Patent europeic · EP1490024 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1490024
Numer da la dumonda
EP03716287
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
06-03-2003
Publitgà
29-12-2004
Concedì
18-01-2012
Stritgà
06-03-2023
Motiv
Durada maximala cuntanschida
Classas IPC
A61K 31/663 (2006.01)
A61K 9/46 (2006.01)
Prioritad
US 92083 06.03.2002
Dumonda PCT
PCT/US2003/006576 06.03.2003
Publicaziun PCT
WO2003/075884 18.09.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 06-03-2023

    Durada maximala cuntanschida

    Published in Swissreg on 06.03.2023

  2. 03-02-2017

    Curregì

    Owner
    EffRx Pharmaceuticals SA, Dr. med.Yvonne Gunsch-Wegmann, MBA MAS Corporate Finance CFO, Wolleraustrasse 41B, 8807 Freienbach → EffRx Pharmaceuticals SA, Wolleraustrasse 41B, 8807 Freienbach

    Published in Swissreg on 03.02.2017

  3. 22-03-2013

    Curregì

    Owner
    EffRx Pharmaceuticals SA, Avenue du Théâtre 1, c/o KPMG SA, 1005 Lausanne → EffRx Pharmaceuticals SA, Dr. med.Yvonne Gunsch-Wegmann, MBA MAS Corporate Finance CFO, Wolleraustrasse 41B, 8807 Freienbach

    Published in Swissreg on 22.03.2013

  4. 18-01-2012

    Concedì

    Published in Swissreg on 18.01.2012

Partidas

Inventur

MCCALLISTER, David

Palm Beach Gardens, FL 33410, US

ROSEN, Christer

Tequesta, FL 33469, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.